• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
Our Caring  >  Our Giving   >  Preventing Diseases   >  Children Without Worms
  • Listen to this page using ReadSpeaker
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Children Without Worms


CloseShare This Page

Globally, up to 400 million children suffer unnecessarily from intestinal worms, but fewer than 20 percent of at-risk children are reached with de-worming treatments. Left untreated, intestinal worms cause severe disability and sometimes death.

A Call to Action
Our global program Children Without Worms, created in partnership with the Task Force for Child Survival and Development, is working with national and international partners to treat up to 25 million children a year with our drug mebendazole.

Partnering for the Future
Children Without Worms goes beyond the donation of mebendazole. To implement sustainable programs that include hygiene education and improved sanitation facilities, the program works to establish partnerships at the international and national levels. For example:

  • Children Without Worms received a grant from the Izumi Foundation to support the distribution of mebendazole and the development of health education materials in Zambia.
  • The program is working in Bangladesh, Uganda and Zambia to convene meetings of all national stakeholders in order to establish strategies that will reduce the burden of intestinal worms through treatment with mebendazole, hygiene education and sanitation improvements.
  • In Cameroon and Zambia, Children Without Worms collaborated with the Ministries of Health to implement surveys to identify children at the highest risk of disease.
  • Four additional countries - Cambodia, Cape Verde, Laos and Nicaragua - are receiving mebendazole donations in 2008.

Children Without Worms will continue to develop partnerships to raise awareness and resources for sustainable control of intestinal worms.

Content for users without Flash here.

Our Giving Around the World

Intestinal Worms Treatment & Prevention
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
Home  >   Our Caring  >  Our Giving  >  Preventing Diseases
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Children Without Worms

Globally, up to 400 million children suffer unnecessarily from intestinal worms, but fewer than 20 percent of at-risk children are reached with de-worming treatments. Left untreated, intestinal worms cause severe disability and sometimes death.

A Call to Action
Our global program Children Without Worms, created in partnership with the Task Force for Child Survival and Development, is working with national and international partners to treat up to 25 million children a year with our drug mebendazole.

Partnering for the Future
Children Without Worms goes beyond the donation of mebendazole. To implement sustainable programs that include hygiene education and improved sanitation facilities, the program works to establish partnerships at the international and national levels. For example:

  • Children Without Worms received a grant from the Izumi Foundation to support the distribution of mebendazole and the development of health education materials in Zambia.
  • The program is working in Bangladesh, Uganda and Zambia to convene meetings of all national stakeholders in order to establish strategies that will reduce the burden of intestinal worms through treatment with mebendazole, hygiene education and sanitation improvements.
  • In Cameroon and Zambia, Children Without Worms collaborated with the Ministries of Health to implement surveys to identify children at the highest risk of disease.
  • Four additional countries - Cambodia, Cape Verde, Laos and Nicaragua - are receiving mebendazole donations in 2008.

Children Without Worms will continue to develop partnerships to raise awareness and resources for sustainable control of intestinal worms.

  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •